Category:Commentary

Back to News & Events


Primary care holds the key to unlocking guideline-based care
19 July 2022

Why is primary care important now? Achieving new standards for heart failure will require awareness-raising, investment and reform in primary care.

Read More
Are we failing women with heart failure?
07 June 2022

It has been argued that women are systematically discriminated against in healthcare, so what does this mean for women with heart failure?

Read More
The future of heart failure care – key lessons learnt from the pandemic
11 March 2022

After two years of disruption, many countries are lifting COVID-19 restrictions. We have been talking with the HFPN community about the key lessons learnt from the pandemic and how they can help shape the future of heart failure care.

Read More
Inside the minds of decision-makers: what did we learn at the 2021 Heart Failure Policy Summit?
10 December 2021

What links a dog dressed as a fairy, an MP with a new heart, and Michelle Obama? Network Director Joe Farrington-Douglas reflects on what we learned from the inaugural 2021 Heart Failure Policy Summit.

Read More
Thoughts from the front line: heart failure services during the COVID-19 pandemic
23 June 2021

In this guest blog post, heart failure nurse consultant Carys Barton shares the challenges faced and innovative solutions implemented at Imperial College Healthcare NHS Trust in London.

Read More
The unique opportunities for heart failure specialists in England’s restructured cardiac services
07 May 2021

Dr Simon Williams examines the future of cardiac services in England, and how heart failure specialists can have a vital role.

Read More
How can the EU support Member States’ efforts to overcome challenges in heart failure policy and care?
02 March 2021

This video series examines the heart failure policy priorities different stakeholder would like to see, including healthcare professionals, patient advocates and policymakers.

Read More
The data dearth hampering heart failure care
08 May 2017

Despite affecting 15 million people across the EU, heart failure is poorly understood, partly because we are not collecting adequate data.

Read More
The Heart Failure Policy Network is made possible with financial support from AstraZeneca, Vifor Pharma, Bayer AG and Boehringer Ingelheim. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.